세계의 혈전 관리 기기 시장 : 제품별, 최종 사용자별 예측(2025-2030년)

The Clot Management Devices Market was valued at USD 1.95 billion in 2023, expected to reach USD 2.06 billion in 2024, and is projected to grow at a CAGR of 5.73%, to USD 2.88 billion by 2030.

Clot management devices are essential within the medical device industry, focusing primarily on the treatment and prevention of thrombotic conditions such as deep vein thrombosis, pulmonary embolism, and stroke. These devices range from catheters and thrombectomy devices to mechanical thrombectomy systems, primarily used across hospitals, clinics, and ambulatory surgical centers. The increasing prevalence of sedentary lifestyles, coupled with an aging population, has led to a rise in thrombotic disorders, accentuating the necessity for effective clot management solutions. This surge is a key growth factor for the market, coupled with technological advancements, such as the development of next-generation thrombectomy devices which offer minimally invasive and enhanced treatment efficacy. However, factors such as stringent regulatory approvals and the high costs associated with advanced devices pose significant challenges. Emerging opportunities lie in expanding telemedicine and remote monitoring solutions that can be integrated with clot management systems, enhancing accessibility and patient management. Additionally, the increasing focus on personalized medicine could pave the way for innovations in patient-specific devices that improve outcomes. Businesses can capitalize on these opportunities by investing in research and development to create nimble, cost-effective, and high-performance devices that meet evolving healthcare standards. Active partnerships and collaborations with healthcare providers and technological firms can also facilitate deeper market penetration and innovation sharing. Nevertheless, navigating fluctuating reimbursement policies and adapting to regional disparities in healthcare infrastructure remain ongoing challenges. Market players should prioritize staying abreast of regulatory changes and invest in training healthcare professionals for better adoption of new technologies. By focusing on the areas of innovation like AI-driven diagnostic tools and biodegradable materials for clot retrieval, companies can address unmet needs and capture a broader segment. The market is distinctly competitive, necessitating strategic agility and robust research strategies for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clot Management Devices Market

The Clot Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing critical diseases including coronary heart diseases and peripheral arterial diseases
  • Rising elderly population closer to higher risk to diseases development
  • Demand for effective thrombectomy/embolectomy devices
• Market Restraints
  • Conventional method practices in several economies
• Market Opportunities
  • Increasing investments to develop healthcare facilities
  • Higher acceptance of percutaneous devices
• Market Challenges
  • Dearth of skilled physician and lack of reimbursement

Porter's Five Forces: A Strategic Tool for Navigating the Clot Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clot Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clot Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clot Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clot Management Devices Market

A detailed market share analysis in the Clot Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clot Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clot Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clot Management Devices Market

A strategic analysis of the Clot Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clot Management Devices Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, AngioDynamics, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, F. Hoffmann-La Roche AG, GE Healthcare, LeMaitre Vascular, Inc., Medela AG, Medtronic PLC, Merck KGaA, Merit Medical Systems, Inc, Penumbra, Inc, Siemens AG, Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Clot Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Catheter-Directed Thrombolysis devices, Embolectomy Balloon Catheters, Inferior Vena Cava Filters, Neurovascular Embolectomy Devices, and Percutaneous Thrombectomy Devices.
• Based on End-User, market is studied across Diagnostic Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing critical diseases including coronary heart diseases and peripheral arterial diseases
    • 5.1.1.2. Rising elderly population closer to higher risk to diseases development
    • 5.1.1.3. Demand for effective thrombectomy/embolectomy devices
  • 5.1.2. Restraints
    • 5.1.2.1. Conventional method practices in several economies
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments to develop healthcare facilities
    • 5.1.3.2. Higher acceptance of percutaneous devices
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled physician and lack of reimbursement
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clot Management Devices Market, by Product

• 6.1. Introduction
• 6.2. Catheter-Directed Thrombolysis devices
• 6.3. Embolectomy Balloon Catheters
• 6.4. Inferior Vena Cava Filters
• 6.5. Neurovascular Embolectomy Devices
• 6.6. Percutaneous Thrombectomy Devices

7. Clot Management Devices Market, by End-User

• 7.1. Introduction
• 7.2. Diagnostic Centers
• 7.3. Hospitals

8. Americas Clot Management Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Clot Management Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Clot Management Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acandis GmbH
• 2. AngioDynamics, Inc.
• 3. Becton, Dickinson and Company
• 4. Boston Scientific Corporation
• 5. Edwards Lifesciences Corporation
• 6. F. Hoffmann-La Roche AG
• 7. GE Healthcare
• 8. LeMaitre Vascular, Inc.
• 9. Medela AG
• 10. Medtronic PLC
• 11. Merck KGaA
• 12. Merit Medical Systems, Inc
• 13. Penumbra, Inc
• 14. Siemens AG
• 15. Teleflex Incorporated
• 16. Terumo Corporation